The company's application included a submitted dose of 0.04 millimole gadolinium per kilogram of body weight. If approved, gadoquatrane would become the lowest dose macrocyclic gadolinium-based ...

Bayer today announced the submission of a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for its investigational contrast agent gadoquatrane for contrast-enhanced magnetic ...

Lahore: Punjab Chief Minister Maryam Nawaz Sharif arrived at Mayo Hospital on Tuesday to get herself medically examined. Senior doctors asvised the chief minister to go through Magnetic Resonance ...

Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (“Lipella” or the “Company”), a clinical-stage biotechnology company focused on ...

Repeated TBIs are linked to an increased risk of neurodegenerative diseases like early-onset dementia, which has the highest ...

Berlin: Bayer has announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for ...